Skip to main content
David Boyer, MD, Ophthalmology, Los Angeles, CA

David S Boyer MD

Retinal Disease, Uveitis, Ocular Oncology


Clinical Professor of Ophthalmology, USC School of Medicine

Join to View Full Profile
  • 1245 Wilshire BlvdSte 380Los Angeles, CA 90017

  • Phone+1 213-483-8810

  • Fax+1 213-975-9118

Dr. Boyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1976 - 1977
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1973 - 1976
  • University of Southern California/LACUSC Medical Center
    University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1972 - 1973
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - 2027
  • HI State Medical License
    HI State Medical License Active through 2014
  • PA State Medical License
    PA State Medical License 1976 - 1978
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Super Doctor SuperDoctors.com
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • UNITY Biotech Reveals Topline Results from Senolytic DME Trial
    UNITY Biotech Reveals Topline Results from Senolytic DME TrialMarch 25th, 2025
  • Unity Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in DME
    Unity Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in DMEMarch 24th, 2025
  • Light Therapy Might Help Ease 'Dry' Form of Macular Degeneration
    Light Therapy Might Help Ease 'Dry' Form of Macular DegenerationOctober 22nd, 2024
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: